CORRIGENDUM: Commentary on Pharmacometrics for Immunotherapy
نویسندگان
چکیده
The authors note an error in the second paragraph of the BACKGROUND section. The paragraph should read as set below. Corrected text is set in bold type. The current issue of CPT: Pharmacometrics & Systems Pharmacology focuses on the application of population pharma-cokinetic/pharmacodynamics analysis (popPKPD) to the clinical development of two new immune-modulatory agents acting as antagonists of the PD
منابع مشابه
Commentary on Pharmacometrics for Immunotherapy
This commentary provides an overview of recent examples of pharmacometrics applied during the clinical development of two antagonists of the programmed death-1 (PD-1) cell surface receptor, pembrolizumab and nivolumab. Despite the remarkable achievements obtained in predicting the correct dosing schedule from different quantitative approaches, data indicated a great degree of heterogeneity in t...
متن کاملCorrigendum: Subcutaneous and Sublingual Immunotherapy in Allergic Asthma in Children
[This corrects the article on p. 82 in vol. 5, PMID: 28484690.].
متن کاملCorrigendum to “Sarcoma Immunotherapy: Past Approaches and Future Directions”
[This corrects the article DOI: 10.1155/2014/391967.].
متن کاملChallenges and Opportunities for Quantitative Clinical Pharmacology in Cancer Immunotherapy: Something Old, Something New, Something Borrowed, and Something Blue
Cancer immunotherapy (CIT) initiates or enhances the host immune response against cancer. Following decades of development, patients with previously few therapeutic options may now benefit from CIT. Although the quantitative clinical pharmacology (qCP) of previous classes of anticancer drugs has matured during this time, application to CIT may not be straightforward since CIT acts via the immun...
متن کاملCorrigendum to "On $(sigma, tau)$-module extension Banach algebras"
In this corrigendum, we give a correction of one result in reference [1].
متن کامل